Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Validation and Regulation of Clinical Artificial Intelligence
16
Zitationen
3
Autoren
2019
Jahr
Abstract
The digital transformation of healthcare has generated a wealth of new information, ranging from electronic health records to patient-generated data. The availability of these data has led to the rapid adoption of artificial intelligence in medicine. Although these algorithms have the potential to guide precision therapies, improve efficiency, and achieve better outcomes, there has been limited regulatory oversight to assess the quality and efficacy of predictive algorithms in the clinical setting. Recent articles by Parikh et al. in Science and Collins and Moons in The Lancet and draft guidance from the Food and Drug Administration have started to explore reporting and regulatory frameworks for predictive algorithms (1–3). Recent draft guidance from the Food and Drug Administration on clinical decision support systems and artificial intelligence in software as a medical device has started …
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.200 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.051 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.416 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.410 Zit.